New Treatment of Cardiac Device Infections; Immediate Reimplantation After Removal of Infected System

Recruiting now · Phase 3

Conditions studied: Endocarditis, Bacterial

In brief

The goal of this randomized clinical trials is to ascertain the safety and efficacy of immediate reimplantation of cardiac electronic implantable devices in patients with endocarditis and device-infections, compared to standard care, i.e. reimplantation at a later procedure date. The primary outcome is the occurence of the composite primary endpoint within 6 months of randomization consisting of * Death * Symptomatic embolism (systemic arterial embolism or pulmonary embolism) * Bacteremia og pocket-infection * Removal of a CIED due to new infection

Key facts

Study ID
NCT06250985
Run by
Rigshospitalet, Denmark
People needed
176
Starts
2024-04-29
Expected to finish
2037-12-31
Last updated by the study team
2025-10-08

Who can join

Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.